Adagene partners with Incyte for cancer drug combination study
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- Wall St rises as Anthropic's IPO filing sharpens focus on AI trade
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
| (NASDAQ: ADAG) | Delayed: 2.35 -0.06 (2.49%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.41 | 52 Week High | $ | |||
| Open | $2.42 | 52 Week Low | $ | |||
| Day High | $2.50 | P/E | N/A | |||
| Day Low | $2.34 | EPS | $ | |||
| Volume | 4,084 | |||||
| Incyte Genomics, Inc. (NASDAQ: INCY) | Delayed: 113.80 -1.91 (1.65%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $115.71 | 52 Week High | $118.49 | |||
| Open | $115.49 | 52 Week Low | $55.00 | |||
| Day High | $115.93 | P/E | N/A | |||
| Day Low | $112.93 | EPS | $-0.56 | |||
| Volume | 724,311 | |||||
